−1.196 EUR
−28.34 M EUR
−3.62 M EUR
20.19 M
About VIVORYON THERAPEUTICS N.V.
Sector
Industry
CEO
Frank T. Weber
Website
Headquarters
Halle
Founded
2001
ISIN
NL00150002Q7
FIGI
BBG007BQJ1C8
Vivoryon Therapeutics NV is a biopharmaceutical company, which engages in the research and development of therapeutic products for the treatment of Alzheimer's disease. Its product pipeline includes PQ912, PBD-C06, and PQ1565. The company was founded by Hans-Ulrich Demuth and Konrad Glund on July 25, 1997 and is headquartered in Halle, Germany.
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Related stocks
Frequently Asked Questions
The current price of VVYN is 1.934 EUR — it has decreased by −0.51% in the past 24 hours. Watch VIVORYON THERAPEUTICS NV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on VIE exchange VIVORYON THERAPEUTICS NV stocks are traded under the ticker VVYN.
VVYN stock has fallen by −0.21% compared to the previous week, the month change is a −0.21% fall, over the last year VIVORYON THERAPEUTICS NV has showed a −0.82% decrease.
We've gathered analysts' opinions on VIVORYON THERAPEUTICS NV future price: according to them, VVYN price has a max estimate of 9.00 EUR and a min estimate of 2.00 EUR. Watch VVYN chart and read a more detailed VIVORYON THERAPEUTICS NV stock forecast: see what analysts think of VIVORYON THERAPEUTICS NV and suggest that you do with its stocks.
VVYN stock is 1.14% volatile and has beta coefficient of 2.78. Track VIVORYON THERAPEUTICS NV stock price on the chart and check out the list of the most volatile stocks — is VIVORYON THERAPEUTICS NV there?
Yes, you can track VIVORYON THERAPEUTICS NV financials in yearly and quarterly reports right on TradingView.
VVYN net income for the last half-year is −13.56 M EUR, while the previous report showed −17.63 M EUR of net income which accounts for 23.07% change. Track more VIVORYON THERAPEUTICS NV financial stats to get the full picture.
No, VVYN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Mar 22, 2025, the company has 17.00 employees. See our rating of the largest employees — is VIVORYON THERAPEUTICS NV on this list?
Like other stocks, VVYN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VIVORYON THERAPEUTICS NV stock right from TradingView charts — choose your broker and connect to your account.